CVE-2023-53734
Unknown Unknown - Not Provided
BaseFortify

Publication date: 2025-12-04

Last updated on: 2025-12-08

Assigner: VulnCheck

Description
dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
CVSS Scores
EPSS Scores
Probability:
Percentile:
Meta Information
Published
2025-12-04
Last Modified
2025-12-08
Generated
2026-05-07
AI Q&A
2025-12-10
EPSS Evaluated
2026-05-05
NVD
Affected Vendors & Products
Showing 1 associated CPE
Vendor Product Version / Range
mayuri dawa-pharma 1.0-2022
Helpful Resources
Exploitability
CWE
CWE Icon
KEV
KEV Icon
CWE ID Description
CWE-89 The product constructs all or part of an SQL command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended SQL command when it is sent to a downstream component. Without sufficient removal or quoting of SQL syntax in user-controllable inputs, the generated SQL query can cause those inputs to be interpreted as SQL instead of ordinary user data.
Attack-Flow Graph
AI Powered Q&A
How does this vulnerability affect compliance with common standards and regulations (like GDPR, HIPAA)?:

The vulnerability allows unauthenticated attackers to execute SQL queries on the server, accessing sensitive information and potentially gaining administrative access. This unauthorized access to sensitive data could lead to non-compliance with data protection regulations such as GDPR and HIPAA, which require safeguarding personal and health-related information against unauthorized access and breaches. Therefore, exploitation of this vulnerability poses a significant risk to compliance with these standards. [3, 5]


Can you explain this vulnerability to me?

This vulnerability in dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server. This means attackers can run database commands without logging in, potentially accessing sensitive information and gaining administrative control over the system.


How can this vulnerability impact me? :

The impact of this vulnerability includes unauthorized access to sensitive data stored in the database and the possibility for attackers to gain administrative access, which could lead to data breaches, data manipulation, and full system compromise.


How can this vulnerability be detected on my network or system? Can you suggest some commands?

This vulnerability can be detected by testing the 'email' parameter in POST requests to the dawa-pharma 1.0-2022 application for SQL injection. Example commands include sending payloads that test for Boolean-based blind SQL injection, such as: `email=-8698' OR 5305=5305-- vvuH`, which manipulates the SQL query to always evaluate true. Another method is time-based blind SQL injection using MySQL's SLEEP function to detect delays caused by injected queries. These tests can be performed using tools like curl or SQL injection testing tools targeting the 'email' parameter to confirm if SQL queries are executed. Monitoring for unusual SQL query patterns or unexpected database responses can also help detect exploitation attempts. [5]


What immediate steps should I take to mitigate this vulnerability?

Immediate mitigation steps include implementing proper input validation and sanitization on the 'email' parameter to prevent SQL injection. Use prepared statements or parameterized queries in the application code to avoid direct concatenation of user input into SQL queries. Additionally, restrict database permissions to limit the impact of any potential injection. If possible, update or patch the dawa-pharma software to a version that addresses this vulnerability. Monitoring and blocking suspicious requests targeting the 'email' parameter can also help reduce risk until a permanent fix is applied. [3, 5]


Ask Our AI Assistant
Need more information? Ask your question to get an AI reply (Powered by our expertise)
0/70
EPSS Chart